The mechanism of actions of 3-(5'-(hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) on Ca2+-activated K+ currents in GH3 lactotrophs

Neuropharmacology

Volumn 39, Issue 10, 2000, Pages 1788-1799

  Wu, Sheng Nan ^a   Hwang, Tsong Long ^b   Teng, Che Ming ^b   Li, Hui Fang ^a   Jan, Chung Ren ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ca2+ activated K+ channels; K+ current; lactotrophs; YC 1 (3 (5' hydroxymethyl 2' furyl) 1 benzyl indazole)

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CYCLIC GMP; GUANYLATE CYCLASE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CELL STRAIN GH3; CONTROLLED STUDY; IC 50; INOTROPISM; ION CURRENT; NONHUMAN; POTASSIUM CURRENT; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; INDAZOLES; MEMBRANE POTENTIALS; POTASSIUM CHANNELS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034053627     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00025-3     Document Type: Article

References (29)

1. 2+: a story with a complex past and a promising future. Trends in Pharmacological Sciences. 18:1997;266-269.
2. Ca channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid. Neuropharmacology. 35:1996;949-961.
3. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Molecular Pharmacology. 53:1998;123-127.
4. Friebe A., Schultz G., Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO Journal. 15:1996;6863-6868.
5. Hackos D.H., Korenbrot J.L. Calcium modulation of ligand affinity in the cyclic GMP-gated ion channels of cone photoreceptors. Journal of General Physiology. 110:1997;515-528.
6. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell free membrane patches. Pfluegers Archiv. 391:1981;85-100.
7. Hare J.M., Colucci W.S. Role of nitric oxide in the regulation of myocardial function. Progress in Cardiovascular Diseases. 38:1995;155-166.
8. Hare J.M., Loh E., Creager M.A., Colucci W.S. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
9. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annual Review of Pharmacology and Toxicology. 30:1990;535-560.
10. + channels in rat lactotrophs: reversal by long-term exposure to dopamine agonist. Endocrinology. 138:1997;3141-3153.
11. Ko F.N., Wu C.C., Kuo S.C., Lee F.Y., Teng C.M. YC-1, a novel activator of platelet guanylate cyclase. Blood. 84:1994;4226-4233.
12. Kusaka S., Dabin I., Barnstable C.J., Puro D.G. cGMP-mediated effects on the physiology of bovine and human retinal Müller (glia) cells. Journal of Physiology. 497:1996;813-824.
13. + channels in a pituitary cell line. Journal of Physiology. 425:1990;117-132.
14. 2+ influx. Journal of Neuroscience. 16:1996;1702-1709.
15. Mülsch A., Bauersachs J., Schäfer A., Stasch J.-P., Kast R., Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. British Journal of Pharmacology. 120:1997;681-689.
16. + channels by novel benzimidazolone. European Journal of Pharmacology. 251:1994;53-59.
17. Robitaille R., Garcia M.L., Kaczorowski G.J., Charlton M. Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release. Neuron. 11:1993;645-655.
18. Shirayama T., Pappano A.J. Biphasic effects of intrapipette cyclic guanosine monophosphate on L-type calcium current and contraction of guinea pig ventricular myocytes. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1274-1281.
19. 3. American Journal of Physiology. 261:1991;E66-E75.
20. Thompson S.H. Cyclic GMP-gated channels in a sympathetic neuron cell line. Journal of General Physiology. 110:1997;155-164.
21. Wegener J.W., Nawrath H. Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle. European Journal of Pharmacology. 323:1997;89-91.
22. Wegener J.W., Gath I., Förstermann U., Nawrath H. Activation of soluble gunaylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. British Journal of Pharmacology. 122:1997;1523-1529.
23. 3 cells. FEBS Letters. 386:1996;39-42.
24. Wu C.C., Ko F.N., Kuo S.C., Lee F.Y., Teng C.M. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. British Journal of Pharmacology. 116:1995;1973-1978.
25. Wu S.N., Hwang T.L., Jan C.R., Tseng C.J. Ionic mechanisms of tetrandrine in cultured rat aortic smooth muscle cells. European Journal of Pharmacology. 327:1997;233-238.
26. + channels by extracellular ATP and UTP in rat atrial myocytes. Journal of Cardiovascular Pharmacology. 31:1998;203-211.
27. 2+ current. Brain Research. 812:1998;133-141.
28. 3 cells. Neuropharmacology. 38:1999;979-989.
29. Yoshina S., Kuo S.C. Studies on heterocyclic compounds. XXXXV. Synthesis of furo[3,2-C]pyrazole derivatives. (2) Electrophilic substitution of 1,3-diphenylfuro[3,2-C]pyrazole. Yakugaku Zasshi. 98:1978;204-208.